UBE2I expression showed favorable prognostic value in COAD, LIHC, and PAAD (log-rank P = 0.025, 0.009, and 0.004; Figures 5(b), 5(d), and 5(e)), but not in other cancer types. This evidence concerns the gene UBE2I and cancer.